Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
2.950
+0.040 (1.37%)
At close: Feb 21, 2025, 4:00 PM
2.910
-0.040 (-1.36%)
After-hours: Feb 21, 2025, 4:35 PM EST
Mustang Bio Employees
Mustang Bio had 80 employees as of December 31, 2023. The number of employees decreased by 33 or -29.20% compared to the previous year.
Employees
80
Change (1Y)
-33
Growth (1Y)
-29.20%
Revenue / Employee
n/a
Profits / Employee
-$292,700
Market Cap
6.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MBIO News
- 11 days ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 12 days ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 16 days ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 5 weeks ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - Mustang Bio Receives Positive Listing Determination from Nasdaq - GlobeNewsWire
- 3 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - GlobeNewsWire
- 4 months ago - Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - GlobeNewsWire
- 8 months ago - Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) - GlobeNewsWire